Virex Pharma is developing novel nanotechnology formulations of an antiviral drug for the treatment of infections caused by Respiratory Syncytial Virus (RSV), COVID-19 and Dengue virus
Company Details
- Employees
- 1
- Founded
- -
- Address
- 28, 13 Cantonment Street,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://virexpharma.com/
- Keywords
- Respiratory, Nanotechnology, Antiviral Therapies, Pulmonary, Lungs, Respiratory Syncytial Virus, RSV, COVID-19, Dengue, Antiviral, Drugs.
- HQ
- Fremantle, WA
Virex Pharma Questions
Virex Pharma's website is https://virexpharma.com/
Virex Pharma's LinkedIn profile is https://au.linkedin.com/company/virex-pharma
Virex Pharma has
1 employees.
View email and phone details for 1
employees at Virex Pharma.
Virex Pharma's industry is
Biotechnology Research
Virex Pharma's top competitors are
Oncocross Co., Ltd.,
Allied Legal,
Patiro · Patient Recruitment,
S-Alpha Therapeutics,
Obatica,
Nu Eyne,
Nobo Medicine,
Percheron Therapeutics Limited,
Cyrus Therapeutics,
Cortical Dynamics Limited.
Virex Pharma's categories are Biotechnology Research
Virex Pharma's founding year is 2020
